Home » Topics » BioWorld Science

BioWorld Science
RSS

NP-10679 results in potent neuroprotection in preclinical models

Dec. 1, 2021

Hepatic gene transfer with AAV-GAA leads to enhanced enzyme bioavailability in vivo

Dec. 1, 2021

PQBP1 expression in microglia is important for tau-induced inflammation in the brain

Dec. 1, 2021

NHD2 is essential in Leishmania independently of complex I, emerging as a potential drug target

Nov. 30, 2021

Indomethacin-based PROTACs show pan-coronavirus activity, including SARS-CoV-2 strains

Nov. 30, 2021

Janssen publishes PK/PD data for the anticoagulant-reversing agent JNJ-67842125

Nov. 30, 2021

Polyphenylene carboxymethylene shows anti-SARS-CoV-2 activity in vitro

Nov. 30, 2021

Scorpion Therapeutics unveils lead programs in cancer

Nov. 30, 2021

PNV-2 reduces metastases in animal model of triple-negative breast cancer

Nov. 30, 2021

Discovery of novel antifungal compounds with improved metabolic stability

Nov. 30, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...